Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
62°
Sunny
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pliant Therapeutics, Inc. - Common Stock
(NQ:
PLRX
)
1.540
+0.020 (+1.32%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pliant Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
What's going on in today's after hours session
March 10, 2025
After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via
Chartmill
Pliant Therapeutics Drops IPF Drug Trial After Review, Analyst Flags Uncertain Future
March 04, 2025
Pliant Therapeutics ends its Phase 2b IPF trial for bexotegrast, prompting a Needham downgrade to Hold due to limited catalysts and pipeline challenges.
Via
Benzinga
This Teleflex Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday
March 04, 2025
Via
Benzinga
Get insights into the top gainers and losers of Monday's after-hours session.
March 03, 2025
Discover the top movers in Monday's after-hours session and stay informed about the post-market dynamics.
Via
Chartmill
These Analysts Revise Their Forecasts On Pliant Therapeutics Following Q1 Earnings
May 07, 2024
Via
Benzinga
Here are the top movers in Monday's session.
March 03, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via
Chartmill
Pliant Therapeutics Stock Sinks, Discontinues Mid-Stage Study For Lung Disorder
March 03, 2025
Pliant Therapeutics discontinued its BEACON-IPF trial for bexotegrast due to safety concerns but observed early efficacy. The company plans further data analysis.
Via
Benzinga
Let's take a look at the stocks that are in motion in today's session.
March 03, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via
Chartmill
Which stocks are gapping on Monday?
March 03, 2025
Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps.
Via
Chartmill
Unusual volume stocks in Wednesday's session
February 12, 2025
On Wednesday, there are stocks with unusual volume. Let's take a look.
Via
Chartmill
Which stocks are experiencing notable movement on Monday?
February 10, 2025
Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session.
Via
Chartmill
Crude Oil Rises Sharply; Manhattan Associates Shares Slide
February 10, 2025
Via
Benzinga
Exposures
Fossil Fuels
Let's have a look at the top gainers and losers in the middle of the day of today's session.
February 10, 2025
Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
Via
Chartmill
Nasdaq Surges 1%; ON Semiconductor Shares Plunge Following Earnings Miss
February 10, 2025
Via
Benzinga
This Illumina Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday
February 10, 2025
Via
Benzinga
The market is filled with gapping stocks in Monday's session.
February 10, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps.
Via
Chartmill
Dow Gains 100 Points; McDonald's Shares Rise After Q4 Results
February 10, 2025
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Monday's pre-market session: top gainers and losers
February 10, 2025
Wondering what's happening in Monday's pre-market session? Find an overview in this article.
Via
Chartmill
Pliant Therapeutics Pauses Lead Product Mid-Stage Trial In Patients With Stiff Lung Tissues
February 10, 2025
Pliant Therapeutics halted new enrollment in its BEACON-IPF trial after a safety board review. A separate study showed bexotegrast reduced lung collagen.
Via
Benzinga
Tesla, ON Semiconductor And Other Big Stocks Moving Lower In Monday's Pre-Market Session
February 10, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
February 10, 2025
Via
Benzinga
Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
February 10, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 19, 2024
Via
Benzinga
Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
December 13, 2024
Via
Benzinga
PLRX Stock Earnings: Pliant Therapeutics Misses EPS for Q2 2024
August 07, 2024
PLRX stock results show that Pliant Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
7 Biotech Stocks to Buy on the Dip: June 2024
June 24, 2024
With health being a top priority over wealth generation, these biotech stocks to buy on the dip enjoy a sound framework for speculation.
Via
InvestorPlace
Pliant Therapeutics' Drug Trial Shows Promise In Reversing Lung Fibrosis In Patients
May 14, 2024
Phase 2a trial results of Pliant Therapeutics' bexotegrast (PLN-74809) for idiopathic pulmonary fibrosis. Reduced lung collagen, improved FVC, and cough severity, signaling potential fibrosis...
Via
Benzinga
PLRX Stock Earnings: Pliant Therapeutics Misses EPS for Q1 2024
May 06, 2024
PLRX stock results show that Pliant Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Why Is Liver Disease-Focused Pliant Therapeutics Stock Trading Lower Today?
February 05, 2024
Pliant Therapeutics reports 12-week interim data for bexotegrast in INTEGRIS-PSC Phase 2a trial. 320 mg group met primary and secondary endpoints, showing well-tolerance and reduction in liver...
Via
Benzinga
Why Air Products and Chemicals Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
February 05, 2024
Shares of Air Products and Chemicals, Inc. (NYSE: APD) fell sharply during Monday’s session after the company reported worse-than-expected first-quarter financial results and lowered FY24 adjusted EPS...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.